• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常受试者和遗传性血管性水肿患者体内正常和功能失调的C1抑制剂的行为。

Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.

作者信息

Quastel M, Harrison R, Cicardi M, Alper C A, Rosen F S

出版信息

J Clin Invest. 1983 Apr;71(4):1041-6. doi: 10.1172/jci110831.

DOI:10.1172/jci110831
PMID:6833491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC436961/
Abstract

The metabolism of normal C1 inhibitor and two dysfunctional C1 inhibitors (Ta and WeI) was studied in 10 normal subjects and 8 patients with hereditary angioneurotic edema (HANE), 4 with low antigen concentration (type 1) and 4 with dysfunctional protein (type 2). The fractional catabolic rate of the normal C1 inhibitor in normal subjects was 0.025 of the plasma pool/hour, whereas in HANE subjects it was significantly elevated at 0.035 of the plasma pool/hour. The synthesis of normal C1 inhibitor was decreased in patients with type 1 HANE (0.087 mg/ kg per h compared with 0.218 mg/kg per h). The fractional catabolic rate of dysfunctional protein WeI was similar to normal and showed a slightly accelerated catabolism in patients with HANE, whereas the dysfunctional protein Ta had a strikingly decreased fractional catabolic rate in normals and subjects with HANE. The present study is compatible with reduced C1 inhibitor synthesis in patients with type 1 HANE consistent with a single functional C1 inhibitor gene. The lower than anticipated levels of C1 inhibitor in HANE type 1 appears to result from (a) the single functional gene and (b) increased catabolism of the protein, perhaps related to activation of C1 or other proteases.

摘要

在10名正常受试者和8名遗传性血管性水肿(HANE)患者中研究了正常C1抑制因子和两种功能失调的C1抑制因子(Ta和WeI)的代谢情况,其中4名患者抗原浓度低(1型),4名患者蛋白功能失调(2型)。正常受试者中正常C1抑制因子的血浆池分解代谢率为每小时0.025,而在HANE患者中显著升高,为每小时0.035血浆池。1型HANE患者中正常C1抑制因子的合成减少(每小时0.087毫克/千克,而正常人为每小时0.218毫克/千克)。功能失调蛋白WeI的血浆池分解代谢率与正常情况相似,且在HANE患者中分解代谢略有加速,而功能失调蛋白Ta在正常人和HANE患者中的血浆池分解代谢率显著降低。本研究结果与1型HANE患者中C1抑制因子合成减少一致,提示存在单一功能性C1抑制因子基因。1型HANE患者中C1抑制因子水平低于预期,可能是由于(a)单一功能基因,以及(b)蛋白分解代谢增加,这可能与C1或其他蛋白酶的激活有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/436961/2baa34a8354a/jcinvest00153-0267-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/436961/0b3f0656de7e/jcinvest00153-0267-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/436961/2baa34a8354a/jcinvest00153-0267-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/436961/0b3f0656de7e/jcinvest00153-0267-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9bd/436961/2baa34a8354a/jcinvest00153-0267-b.jpg

相似文献

1
Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema.正常受试者和遗传性血管性水肿患者体内正常和功能失调的C1抑制剂的行为。
J Clin Invest. 1983 Apr;71(4):1041-6. doi: 10.1172/jci110831.
2
The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiency.获得性C1抑制物缺乏症患者中C1抑制物和C1q的代谢
J Allergy Clin Immunol. 1986 Feb;77(2):322-6. doi: 10.1016/s0091-6749(86)80111-7.
3
Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edema.I型和II型遗传性血管性水肿患者成纤维细胞中C1抑制剂的合成
J Clin Invest. 1991 May;87(5):1614-20. doi: 10.1172/JCI115175.
4
Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.遗传性血管性水肿患者血浆中C1抑制物复合物和裂解的C1抑制物水平
J Clin Invest. 1990 Apr;85(4):1215-20. doi: 10.1172/JCI114555.
5
Variability in purified dysfunctional C1(-)-inhibitor proteins from patients with hereditary angioneurotic edema. Functional and analytical gel studies.遗传性血管性水肿患者纯化的功能失调性C1(-)-抑制蛋白的变异性。功能和分析凝胶研究。
J Clin Invest. 1985 Jan;75(1):124-32. doi: 10.1172/JCI111664.
6
Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema.I型遗传性血管性水肿中C1抑制剂合成的反式抑制
J Clin Invest. 1993 Mar;91(3):1258-62. doi: 10.1172/JCI116290.
7
C1-inhibitor--biochemical properties and clinical applications.C1 抑制剂——生化特性与临床应用
Crit Rev Immunol. 1985;5(4):317-30.
8
Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.I型遗传性血管性水肿中补体1抑制因子缺乏的分子基础。
J Clin Invest. 1987 Mar;79(3):698-702. doi: 10.1172/JCI112873.
9
Hereditary and acquired deficiencies of C1 inhibitor.C1抑制剂的遗传性和获得性缺陷
Immunodefic Rev. 1989;1(3):207-26.
10
The catabolism of C1(-)-inhibitor and the pathogenesis of hereditary angio-edema.C1(-)抑制剂的分解代谢与遗传性血管性水肿的发病机制
Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:35-9.

引用本文的文献

1
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers.导致荨麻疹和血管性水肿的遗传变异及其相关生物标志物。
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2286-2301. doi: 10.1016/j.jaip.2023.05.031. Epub 2023 May 30.
2
Sugar Matters: Improving In Vivo Clearance Rate of Highly Glycosylated Recombinant Plasma Proteins for Therapeutic Use.糖的重要性:提高用于治疗的高糖基化重组血浆蛋白的体内清除率。
Pharmaceuticals (Basel). 2021 Jan 11;14(1):54. doi: 10.3390/ph14010054.
3
Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight.

本文引用的文献

1
Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein.遗传性血管性水肿。II. 血清球蛋白通透性因子和/或血浆激肽释放酶抑制剂缺乏。
J Allergy. 1962 Jul-Aug;33:330-41. doi: 10.1016/0021-8707(62)90032-1.
2
HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.遗传性血管性水肿:两种基因变异体。
Science. 1965 May 14;148(3672):957-8. doi: 10.1126/science.148.3672.957.
3
THE METABOLISM OF GAMMA GLOBULINS IN MYELOMA AND ALLIED CONDITIONS.骨髓瘤及相关病症中γ球蛋白的代谢
间歇性 C1 抑制剂缺乏症与隐性遗传相关:功能和结构见解。
Sci Rep. 2018 Jan 17;8(1):977. doi: 10.1038/s41598-017-16667-w.
4
HAE Pathophysiology and Underlying Mechanisms.遗传性血管性水肿的病理生理学及潜在机制。
Clin Rev Allergy Immunol. 2016 Oct;51(2):216-29. doi: 10.1007/s12016-016-8561-8.
5
Genetics of Hereditary Angioedema Revisited.遗传性血管性水肿的遗传学再探讨。
Clin Rev Allergy Immunol. 2016 Oct;51(2):170-82. doi: 10.1007/s12016-016-8543-x.
6
Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate.皮下注射C1抑制剂浓缩物治疗遗传性血管性水肿替代疗法的II期研究结果
Allergy. 2015 Oct;70(10):1319-28. doi: 10.1111/all.12658. Epub 2015 Aug 11.
7
Pathophysiology of Hereditary Angioedema.遗传性血管性水肿的病理生理学
Pediatr Allergy Immunol Pulmonol. 2014 Dec 1;27(4):159-163. doi: 10.1089/ped.2014.0425.
8
The pathophysiology of hereditary angioedema.遗传性血管性水肿的病理生理学。
World Allergy Organ J. 2010 Sep;3(9 Suppl):S25-8. doi: 10.1097/WOX.0b013e3181f3f21c.
9
Angioedema.血管性水肿。
World Allergy Organ J. 2008 Jun;1(6):103-13. doi: 10.1097/WOX.0b013e31817aecbe.
10
Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency.C1 抑制剂缺乏所致血管性水肿患者的凝血和纤溶改变。
Clin Exp Immunol. 2012 Mar;167(3):472-8. doi: 10.1111/j.1365-2249.2011.04541.x.
J Clin Invest. 1963 Dec;42(12):1858-68. doi: 10.1172/JCI104870.
4
A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.遗传性血管神经性水肿中的一种生化异常:血清C1酯酶抑制剂缺失
Am J Med. 1963 Jul;35:37-44. doi: 10.1016/0002-9343(63)90162-1.
5
The theory of tracer experiments with 131I-labelled plasma proteins.用131I标记血浆蛋白的示踪实验理论
Phys Med Biol. 1957 Jul;2(1):36-53. doi: 10.1088/0031-9155/2/1/305.
6
Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.阿尔珀·C·A、罗森·F·S:对正常受试者和患者体内人补体C3行为的研究。
J Clin Invest. 1967 Dec;46(12):2021-34. doi: 10.1172/JCI105691.
7
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.在含有抗体的琼脂糖凝胶中通过电泳对蛋白质进行定量估计。
Anal Biochem. 1966 Apr;15(1):45-52. doi: 10.1016/0003-2697(66)90246-6.
8
Enzymatic and immunochemical estimation of C'1 esterase inhibitor in sera from patients with hereditary angioneurotic edema.遗传性血管性水肿患者血清中C'1酯酶抑制剂的酶法和免疫化学测定
Scand J Clin Lab Invest. 1969 Oct;24(3):221-5. doi: 10.3109/00365516909080156.
9
The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.通过免疫溶血抑制来进行血清对补体第一成分抑制作用的化学计量测量。
J Immunol. 1968 Jun;100(6):1154-64.
10
Analysis of disappearance time-curves after single injection of labelled proteins.单次注射标记蛋白质后消失时间曲线的分析
Ciba Found Symp. 1972;9:113-30. doi: 10.1002/9780470719923.ch7.